Skip to main content

TFS was selected to rescue a phase 3 onychomycosis study from another CRO that was unable to meet the recruitment expectations of the client. TFS provided full CRO services for this study, which was a multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of a topical treatment for mild to moderate distal subungual onychomycosis.